Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy

• Published in: Asia-Pacific journal of clinical oncology 2016-06, Vol.12 (2), p.e289-e297
• Main Authors: Nowroozi, Mohammad Reza, Amini, Shahab, Kasaeian, Amir, Zavarehei, Mansour Jamali, Eshraghian, Mohammad Reza, Ayati, Mohsen
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biopsy - methods; Digital Rectal Examination; Humans; Iran; Kallikreins - blood; Logistic Models; Male; Middle Aged; Nomograms; Predictive Value of Tests; Prognosis; prostate; prostate-specific antigen; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - pathology; Reproducibility of Results; ROC Curve; validation studies
• ISSN: 1743-7555; 1743-7563
• DOI: 10.1111/ajco.12186

Aim Our aim was to establish, validate and compare two nomograms in an Iranian population for the first time using clinical, laboratory and transrectal ultrasonography (TRUS) findings for predicting prostate cancer at initial biopsy. Methods Data were collected on a total of 916 men referred for an initial prostate biopsy in our center in a 7‐year period. Variables analyzed included age, prostate‐specific antigen (PSA), free/total PSA (%fPSA), digital rectal examination (DRE) findings, prostate volume (PV) and presence of hypoechoic lesion on TRUS. Univariate logistic regression models were fitted to test cancer predictors. Two multivariate logistic regression models were fitted to create nomograms. Both models were internally validated. Calibration of nomograms was assessed graphically. The area under the receiver operating characteristic curve (AUC) was calculated as a scale of discrimination and predictive accuracy and also used to compare models. Results Prostate cancer was detected in 221/669 (33%) men. Based on univariate logistic regression, all of variables except DRE were significant predictors of prostate cancer, with highest AUC for PV (AUC 0.696, 95% CI 0.653–0.738).AUC of nomogram with and without TRUS findings and PSA alone were 0.791, 0.721 and 0.624, respectively. In internal validation, both nomograms had acceptable calibration plots. Conclusion Our nomogram based on age, DRE, PSA, %fPSA and TRUS finding was significantly more accurate in predicting initial prostate biopsy outcome in men.